Loading…
Kure CBD & Vape was cited for manufacturing and distributing e-liquid products containing nicotine without required premarket authorization, violating the Family Smoking Prevention and Tobacco Control Act. The FDA determined these products fall under its jurisdiction as tobacco products because they contain nicotine from any source and are intended for human consumption, regardless of whether the nicotine derives from tobacco. The company failed to comply with section 910 of the Federal Food, Drug, and Cosmetic Act, which requires "new tobacco products" to obtain marketing authorization orders before being legally sold in the United States.